Abstract

The ability to accurately diagnose at the point of care is crucial in many pathologies. However, current standard diagnostic practices can only be performed in specialized health or laboratory settings. To move diagnostic methods from a specialized lab to the point of care many alternate methods have been developed and proposed. Among them surface-enhanced Raman scattering (SERS) sensing offers advantageous features, such as simultaneous detection of multiple biotargets and increased accuracy. Many groups have been working towards the translation of SERS sensing methods from the lab to the point of need. In this mini review, we discuss interesting and recent developments in this effort, focusing on how different sensing mechanism can be used in point-of-care testing applications of SERS.

Highlights

  • The ability for accurately point-of-care (POC) diagnosis is crucial for many diseases to ensure early intervention and/or reduce the disease spread

  • The amplification arises from the localized surface plasmon resonance, a collective oscillation of conductive band electrons produced by the interaction with light at a specific wavelength (Moskovits, 2005)

  • The detection was performed on RNA extracted directly from tissue samples collected during surgery and the results showed a high diagnostic accuracy for squamous cell carcinoma (SCC) diagnosis, without the need for any target amplification

Read more

Summary

Steven Quarin and Pietro Strobbia *

The ability to accurately diagnose at the point of care is crucial in many pathologies. To move diagnostic methods from a specialized lab to the point of care many alternate methods have been developed and proposed. Among them surface-enhanced Raman scattering (SERS) sensing offers advantageous features, such as simultaneous detection of multiple biotargets and increased accuracy. Many groups have been working towards the translation of SERS sensing methods from the lab to the point of need. In this mini review, we discuss interesting and recent developments in this effort, focusing on how different sensing mechanism can be used in point-of-care testing applications of SERS

INTRODUCTION
DISCUSSION
CONCLUSION AND PERSPECTIVES
Immunoassay of the PSA Cancer Marker Using SERS and Droplet
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call